Identification of key regions and residues controlling Aβ folding and assembly
- PMID: 28974765
- PMCID: PMC5626695
- DOI: 10.1038/s41598-017-10845-6
Identification of key regions and residues controlling Aβ folding and assembly
Abstract
Amyloid β-protein (Aβ) assembly is hypothesized to be a seminal neuropathologic event in Alzheimer's disease (AD). We used an unbiased D-amino acid substitution strategy to determine structure-assembly relationships of 76 different Aβ40 and Aβ42 peptides. We determined the effects of the substitutions on peptide oligomerization, secondary structure dynamics, fibril assembly dynamics, and fibril morphology. Our experiments revealed that the assembly of Aβ42 was more sensitive to chiral substitutions than was Aβ40 assembly. Substitutions at identical positions in the two peptides often, but not always, produced the same effects on assembly. Sites causing substantial effects in both Aβ40 and Aβ42 include His14, Gln15, Ala30, Ile31, Met35, and Val36. Sites whose effects were unique to Aβ40 include Lys16, Leu17, and Asn 27, whereas sites unique to Aβ42 include Phe20 and Ala21. These sites may be appropriate targets for therapeutic agents that inhibit or potentiate, respectively, these effects.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures










Similar articles
-
C-terminal turn stability determines assembly differences between Aβ40 and Aβ42.J Mol Biol. 2013 Jan 23;425(2):292-308. doi: 10.1016/j.jmb.2012.11.006. Epub 2012 Nov 12. J Mol Biol. 2013. PMID: 23154165 Free PMC article.
-
Role of the region 23-28 in Abeta fibril formation: insights from simulations of the monomers and dimers of Alzheimer's peptides Abeta40 and Abeta42.Curr Alzheimer Res. 2008 Jun;5(3):244-50. doi: 10.2174/156720508784533330. Curr Alzheimer Res. 2008. PMID: 18537541 Review.
-
Structural dynamics of the ΔE22 (Osaka) familial Alzheimer's disease-linked amyloid β-protein.Amyloid. 2011 Sep;18(3):98-107. doi: 10.3109/13506129.2011.580399. Epub 2011 Jun 13. Amyloid. 2011. PMID: 21668291 Free PMC article.
-
Effect of amino-acid substitutions on Alzheimer's amyloid-beta peptide-glycosaminoglycan interactions.Eur J Biochem. 2000 Nov;267(21):6353-61. doi: 10.1046/j.1432-1327.2000.01725.x. Eur J Biochem. 2000. PMID: 11029577
-
Electrochemistry of Alzheimer Disease Amyloid Beta Peptides.Curr Med Chem. 2018;25(33):4066-4083. doi: 10.2174/0929867325666180214112536. Curr Med Chem. 2018. PMID: 29446720 Review.
Cited by
-
Formation of a β-Endorphin Corona Mitigates Alzheimer's Amyloidogenesis.Small. 2025 Jul;21(26):e2409392. doi: 10.1002/smll.202409392. Epub 2025 May 19. Small. 2025. PMID: 40384186 Free PMC article.
-
Understanding and controlling amyloid aggregation with chirality.Curr Opin Chem Biol. 2021 Oct;64:1-9. doi: 10.1016/j.cbpa.2021.01.003. Epub 2021 Feb 18. Curr Opin Chem Biol. 2021. PMID: 33610939 Free PMC article. Review.
-
Mimosine functionalized gold nanoparticles (Mimo-AuNPs) suppress β-amyloid aggregation and neuronal toxicity.Bioact Mater. 2021 May 10;6(12):4491-4505. doi: 10.1016/j.bioactmat.2021.04.029. eCollection 2021 Dec. Bioact Mater. 2021. PMID: 34027236 Free PMC article.
-
Unconjugated PLGA nanoparticles attenuate temperature-dependent β-amyloid aggregation and protect neurons against toxicity: implications for Alzheimer's disease pathology.J Nanobiotechnology. 2022 Feb 4;20(1):67. doi: 10.1186/s12951-022-01269-0. J Nanobiotechnology. 2022. PMID: 35120558 Free PMC article.
-
Significance of native PLGA nanoparticles in the treatment of Alzheimer's disease pathology.Bioact Mater. 2022 Jul 15;17:506-525. doi: 10.1016/j.bioactmat.2022.05.030. eCollection 2022 Nov. Bioact Mater. 2022. PMID: 36330076 Free PMC article.
References
-
- De Strooper B. Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process. Phys Rev. 2010;90:465–494. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources